ClinVar Genomic variation as it relates to human health
NM_000179.3(MSH6):c.1979_1980delinsG (p.Lys660fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000179.3(MSH6):c.1979_1980delinsG (p.Lys660fs)
Variation ID: 1783754 Accession: VCV001783754.2
- Type and length
-
Indel, 2 bp
- Location
-
Cytogenetic: 2p16.3 2: 47799962-47799963 (GRCh38) [ NCBI UCSC ] 2: 48027101-48027102 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Nov 29, 2022 May 1, 2024 Apr 27, 2020 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000179.3:c.1979_1980delinsG MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000170.1:p.Lys660fs frameshift NM_001281492.2:c.1589_1590delinsG NP_001268421.1:p.Lys530fs frameshift NM_001281493.2:c.1073_1074delinsG NP_001268422.1:p.Lys358fs frameshift NM_001281494.2:c.1073_1074delinsG NP_001268423.1:p.Lys358fs frameshift NM_001406795.1:c.2075_2076delAAinsG NP_001393724.1:p.Lys692Argfs frameshift NM_001406796.1:c.1979_1980delAAinsG NP_001393725.1:p.Lys660Argfs frameshift NM_001406797.1:c.1682_1683delAAinsG NP_001393726.1:p.Lys561Argfs frameshift NM_001406798.1:c.1979_1980delAAinsG NP_001393727.1:p.Lys660Argfs frameshift NM_001406799.1:c.1454_1455delAAinsG NP_001393728.1:p.Lys485Argfs frameshift NM_001406800.1:c.1979_1980delAAinsG NP_001393729.1:p.Lys660Argfs frameshift NM_001406801.1:c.1682_1683delAAinsG NP_001393730.1:p.Lys561Argfs frameshift NM_001406802.1:c.2075_2076delAAinsG NP_001393731.1:p.Lys692Argfs frameshift NM_001406803.1:c.1979_1980delAAinsG NP_001393732.1:p.Lys660Argfs frameshift NM_001406804.1:c.1901_1902delAAinsG NP_001393733.1:p.Lys634Argfs frameshift NM_001406805.1:c.1682_1683delAAinsG NP_001393734.1:p.Lys561Argfs frameshift NM_001406806.1:c.1454_1455delAAinsG NP_001393735.1:p.Lys485Argfs frameshift NM_001406807.1:c.1454_1455delAAinsG NP_001393736.1:p.Lys485Argfs frameshift NM_001406808.1:c.1979_1980delAAinsG NP_001393737.1:p.Lys660Argfs frameshift NM_001406809.1:c.1979_1980delAAinsG NP_001393738.1:p.Lys660Argfs frameshift NM_001406811.1:c.1073_1074delAAinsG NP_001393740.1:p.Lys358Argfs frameshift NM_001406812.1:c.1073_1074delAAinsG NP_001393741.1:p.Lys358Argfs frameshift NM_001406813.1:c.1985_1986delAAinsG NP_001393742.1:p.Lys662Argfs frameshift NM_001406814.1:c.1073_1074delAAinsG NP_001393743.1:p.Lys358Argfs frameshift NM_001406815.1:c.1073_1074delAAinsG NP_001393744.1:p.Lys358Argfs frameshift NM_001406816.1:c.1073_1074delAAinsG NP_001393745.1:p.Lys358Argfs frameshift NM_001406818.1:c.1682_1683delAAinsG NP_001393747.1:p.Lys561Argfs frameshift NM_001406819.1:c.1682_1683delAAinsG NP_001393748.1:p.Lys561Argfs frameshift NM_001406820.1:c.1682_1683delAAinsG NP_001393749.1:p.Lys561Argfs frameshift NM_001406821.1:c.1682_1683delAAinsG NP_001393750.1:p.Lys561Argfs frameshift NM_001406822.1:c.1682_1683delAAinsG NP_001393751.1:p.Lys561Argfs frameshift NM_001406823.1:c.1073_1074delAAinsG NP_001393752.1:p.Lys358Argfs frameshift NM_001406824.1:c.1682_1683delAAinsG NP_001393753.1:p.Lys561Argfs frameshift NM_001406825.1:c.1682_1683delAAinsG NP_001393754.1:p.Lys561Argfs frameshift NM_001406826.1:c.1811_1812delAAinsG NP_001393755.1:p.Lys604Argfs frameshift NM_001406827.1:c.1682_1683delAAinsG NP_001393756.1:p.Lys561Argfs frameshift NM_001406828.1:c.1682_1683delAAinsG NP_001393757.1:p.Lys561Argfs frameshift NM_001406829.1:c.1073_1074delAAinsG NP_001393758.1:p.Lys358Argfs frameshift NM_001406830.1:c.1682_1683delAAinsG NP_001393759.1:p.Lys561Argfs frameshift NR_176256.1:n.841_842delAAinsG NR_176257.1:n.2068_2069delAAinsG NR_176258.1:n.2068_2069delAAinsG NR_176259.1:n.2068_2069delAAinsG NR_176261.1:n.2068_2069delAAinsG NC_000002.12:g.47799962_47799963delinsG NC_000002.11:g.48027101_48027102delinsG NG_007111.1:g.21816_21817delinsG LRG_219:g.21816_21817delinsG LRG_219t1:c.1979_1980delAAinsG LRG_219p1:p.Lys660Argfs - Protein change
- K358fs, K530fs, K660fs
- Other names
- -
- Canonical SPDI
- NC_000002.12:47799961:AA:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MSH6 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
9161 | 9479 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
criteria provided, single submitter
|
Apr 27, 2020 | RCV002423626.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Apr 27, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002722892.2
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
The c.1979_1980delAAinsG pathogenic mutation, located in coding exon 4 of the MSH6 gene, results from the deletion of two nucleotides and insertion of one nucleotide … (more)
The c.1979_1980delAAinsG pathogenic mutation, located in coding exon 4 of the MSH6 gene, results from the deletion of two nucleotides and insertion of one nucleotide at positions 1979 to 1980, causing a translational frameshift with a predicted alternate stop codon (p.K660Rfs*3). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated May 01, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.